261 related articles for article (PubMed ID: 12729070)
1. Analytical performance of time-resolved fluorometry-based Innotrac Aio! cardiac marker immunoassays.
Hedberg P; Valkama J; Puukka M
Scand J Clin Lab Invest; 2003; 63(1):55-64. PubMed ID: 12729070
[TBL] [Abstract][Full Text] [Related]
2. Innotrac Aio!: a point-of-care or a routine analyzer? Analytical performance and plasma/whole blood comparison.
Altinier S; Zaninotto M; Mion MM; Plebani M
Clin Chem Lab Med; 2006; 44(10):1278-82. PubMed ID: 17032142
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the chemiluminescence immunoassays for the measurement of troponin I, myoglobin and CK-MB using the IMMULITE system in comparison to other measuring systems.
Lestin M; Hergert M; Lestin HG; Brinker C; Storm H; Kuhrt E; Kuhrt B; Lambrecht HG; Kühnel W
Clin Lab; 2002; 48(3-4):211-21. PubMed ID: 11934224
[TBL] [Abstract][Full Text] [Related]
4. Highly sensitive determination of C-reactive protein on the Innotrac Aio! immunoanalyzer.
Hedberg P; Ylitalo K; Puukka M
Scand J Clin Lab Invest; 2004; 64(7):677-85. PubMed ID: 15513325
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic utility of new immunoassays for the cardiac markers cTnI, myoglobin and CK-MB mass.
Weber M; Rau M; Madlener K; Elsaesser A; Bankovic D; Mitrovic V; Hamm C
Clin Biochem; 2005 Nov; 38(11):1027-30. PubMed ID: 16125162
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Stratus CS stat fluorimetric analyser for measurement of cardiac markers Troponin I (cTnI), creatine kinase MB (CK-MB), and myoglobin.
Bénéteau-Burnat B; Baudin B; Vaubourdolle M
J Clin Lab Anal; 2001; 15(6):314-8. PubMed ID: 11793431
[TBL] [Abstract][Full Text] [Related]
7. Method comparison of cardiac marker assays on PATHFAST, StratusCS, AxSYM, Immulite 2000, triage, elecsys and cardiac reader.
Peetz D; Schweigert R; Jachmann N; Post F; Schinzel H; Lackner KJ
Clin Lab; 2006; 52(11-12):605-14. PubMed ID: 17175892
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a point-of-care assay for cardiac markers for patients suspected of acute myocardial infarction.
Wu AH; Smith A; Christenson RH; Murakami MM; Apple FS
Clin Chim Acta; 2004 Aug; 346(2):211-9. PubMed ID: 15256323
[TBL] [Abstract][Full Text] [Related]
9. Comparison of myoglobin, creatine kinase-MB, and cardiac troponin I for diagnosis of acute myocardial infarction.
Wu AH; Feng YJ; Contois JH; Pervaiz S
Ann Clin Lab Sci; 1996; 26(4):291-300. PubMed ID: 8800429
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of serial measurement of cardiac markers in patients with chest pain: limited value of adding myoglobin to troponin I for exclusion of myocardial infarction.
Eggers KM; Oldgren J; Nordenskjöld A; Lindahl B
Am Heart J; 2004 Oct; 148(4):574-81. PubMed ID: 15459585
[TBL] [Abstract][Full Text] [Related]
11. [Quantitative analysis of serum troponin I and myoglobin in patients with acute myocardial infarction].
Xiao HG; Huang ZH; Liu HX; Lin YP
Di Yi Jun Yi Da Xue Xue Bao; 2005 May; 25(5):550-1. PubMed ID: 15897132
[TBL] [Abstract][Full Text] [Related]
12. Comparison of cardiac troponin I versus T and creatine kinase MB after coronary artery bypass grafting in patients with and without perioperative myocardial infarction.
Peivandi AA; Dahm M; Opfermann UT; Peetz D; Doerr F; Loos A; Oelert H
Herz; 2004 Nov; 29(7):658-64. PubMed ID: 15580320
[TBL] [Abstract][Full Text] [Related]
13. Time-resolved fluorometry (TRF)-based immunoassay concept for rapid and quantitative determination of biochemical myocardial infarction markers from whole blood, serum and plasma.
Pettersson K; Katajamäki T; Irjala K; Leppanen V; Majamaa-Voltti K; Laitinen P
Luminescence; 2000; 15(6):399-407. PubMed ID: 11114117
[TBL] [Abstract][Full Text] [Related]
14. Imprecision of cardiac marker analyses among laboratories on the basis of external quality assurance results: Finnish experience.
Penttilä IM; Laatikainen A; Penttilä K; Punnonen K; Rantanen T; Savolainen K; Tiikkainen U
Scand J Clin Lab Invest; 2007; 67(5):507-18. PubMed ID: 17763187
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of innotrac aio! Second-generation cardiac troponin I assay: the main characteristics for routine clinical use.
Hedberg P; Valkama J; Suvanto E; Pikkujämsä S; Ylitalo K; Alasaarela E; Puukka M
J Autom Methods Manag Chem; 2006; 2006():39325. PubMed ID: 17671616
[TBL] [Abstract][Full Text] [Related]
16. Markers of myocardial ischemia in the evaluation of the effect of left anterior descending coronary artery lesion and collateral circulation on myocardial injury in 1-vessel off-pump coronary bypass surgery.
Kirali K; Mansuroğlu D; Kayalar N; Güzelmeriç F; Alp M; Yakut C
Heart Surg Forum; 2003; 6(3):143-8. PubMed ID: 12821428
[TBL] [Abstract][Full Text] [Related]
17. Troponin T or troponin I or CK-MB (or none?).
Collinson PO
Eur Heart J; 1998 Nov; 19 Suppl N():N16-24. PubMed ID: 9857934
[TBL] [Abstract][Full Text] [Related]
18. [The impact of L-carnitine administration on the serum level of myocardium injury markers in patients with acute carbon monoxide poisoning].
Sun ZJ; Yang CB; Wang H; Li Y
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 Dec; 23(12):739-42. PubMed ID: 22153012
[TBL] [Abstract][Full Text] [Related]
19. Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin I.
Bar-Or D; Winkler JV; Vanbenthuysen K; Harris L; Lau E; Hetzel FW
Am Heart J; 2001 Jun; 141(6):985-91. PubMed ID: 11376314
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular disease testing on the Dimension Vista system: biomarkers of acute coronary syndromes.
Kelley WE; Lockwood CM; Cervelli DR; Sterner J; Scott MG; Duh SH; Christenson RH
Clin Biochem; 2009 Sep; 42(13-14):1444-51. PubMed ID: 19523464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
